โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Medicines: 18 in last 7 days ๐ŸŽ Food: 180 in last 7 days ๐Ÿงธ Products: 48 in last 7 days ๐ŸŸข Monitoring: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Last fetch: 3 hours ago โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Medicines: 18 in last 7 days ๐ŸŽ Food: 180 in last 7 days ๐Ÿงธ Products: 48 in last 7 days ๐ŸŸข Monitoring: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Last fetch: 3 hours ago
๐Ÿ›ก๏ธ EUSW
๐Ÿ’Š Medicines ๐ŸŽ Food ๐Ÿงธ Products ๐Ÿ”Ž Search
๐Ÿ“Š Data
๐Ÿท Brands ๐ŸŒ Countries โ„น๏ธ About โœ‰ Unsubscribe
๐Ÿ‡ฌ๐Ÿ‡ง
๐Ÿ‡ฌ๐Ÿ‡ง English ๐Ÿ‡ณ๐Ÿ‡ฑ Nederlands ๐Ÿ‡ซ๐Ÿ‡ท Franรงais ๐Ÿ‡ฉ๐Ÿ‡ช Deutsch ๐Ÿ‡ช๐Ÿ‡ธ Espaรฑol ๐Ÿ‡ฎ๐Ÿ‡น Italiano ๐Ÿ‡ต๐Ÿ‡น Portuguรชs ๐Ÿ‡ต๐Ÿ‡ฑ Polski ๐Ÿ‡ธ๐Ÿ‡ช Svenska ๐Ÿ‡ท๐Ÿ‡ด Romรขnฤƒ ๐Ÿ‡จ๐Ÿ‡ฟ ฤŒeลกtina ๐Ÿ‡ซ๐Ÿ‡ฎ Suomi ๐Ÿ‡ฉ๐Ÿ‡ฐ Dansk
๐Ÿ’Š

Spevigo

spesolimab
Psoriasis
โœ… Authorised
โœ…
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.

What it's used for

Spevigo is indicated for the prevention of generalised pustular psoriasis (GPP) flares in adults and adolescents from 12 years of age. Spevigo is indicated for the treatment of generalised pustular psoriasis (GPP) flares in adults and adolescents from 12 years of age as monotherapy.

โš ๏ธ Patient safety

No

Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/spevigo
โš ๏ธ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.